News and Publications
Publication Categories
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
Explore how the Endothelin B receptor (ETBR) inhibits T cell homing, limiting tumor immunotherapy efficacy. Learn about ICAM-1’s role in immune cell infiltration and how ETBR blockade can enhance cancer treatment outcomes.